UAE has banned travel to 14 countries including India-Pakistan
Australia has reduced the number of commercial tourists from six thousand to three thousand
Six infected died of corona vaccine in Seychelles
New Delhi: The number of delta-type cases in the UK has increased by 46 per cent this week compared to the previous week, with a total of 50,824 cases reported, health officials said. However, with the increase in the number of cases, the number of patients hospitalized for treatment has not increased enough that the corona vaccines are effective against this highly infectious delta variant.
Of the 50,824 cases of the delta B 1.617.2 variant, 42 were of the delta AY1 and mutation K417N. These 42 cases of new variants are feared to be vaccine resistant. Meanwhile, the UAE has banned the travel of its citizens to 14 countries, including India and Pakistan, to prevent the spread of the corona epidemic.
The UAE Ministry of Foreign Affairs and International Cooperation announced that UAE citizens are banned from traveling to India, Pakistan, Bangladesh, Nepal, Sri Lanka, Vietnam, Namibia, Zambia, Congo, Uganda, Sierra Leone, Liberia, South Africa and Nigeria. will be installed. is.
However, diplomatic tourists and other dignitaries are allowed to visit these countries. Meanwhile, Australia has reduced the exemption on arrival for commercial passengers from 6,000 to 3,000. The burden will be eased by July 14 to ease pressure on hotel quarantines, Prime Minister Scott Morris said after a meeting of regional leaders.
Seychelles, on the other hand, became the country with the most vaccinations in May. There are no signs of decline due to the Delta variant. Recently, there were reports of death of six people who took both doses of corona vaccine due to corona infection. Of the six, five were vaccinated against Indian-made Kowishield and one for cyanoform.
On the other hand, Johnson & Johnson claimed that its corona vaccine was effective against the delta variant even after eight months. The company said this while announcing the results of two studies conducted to test the effectiveness of its vaccine against the delta variant.